Evidence map›Paper›PMID 34611887›Full record

ArticleJournal of the American Geriatrics Society2022

Changes in older adults' life space during lung cancer treatment: A mixed methods cohort study.

Melisa L Wong, Ying Shi, Alexander K Smith, Christine Miaskowski, W John Boscardin, Harvey Jay Cohen, Vivian Lam, Melissa Mazor, Lia Metzger, Carolyn J Presley and 9 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Using Patient-Reported Outcome Measures to Identify Mobility Limitation in Incurable Cancer.Archives of rehabilitation research and clinical translation · 2026
    Article
  3. Uncovering the realities of suicidal ideation in older patients following lung cancer diagnosis: an interpretive phenomenological qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 1 country.

Melisa L WongDivision of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0001-6390-6959
Ying ShiDivision of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
Alexander K SmithDivision of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
Christine MiaskowskiDepartments of Physiological Nursing and Anesthesiology and Perioperative Care, University of California San Francisco, San Francisco, California, USA.
W John BoscardinDivision of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
Harvey Jay CohenCenter for the Study of Aging & Human Development and Duke Cancer Institute, Duke University, Durham, North Carolina, USA.
Vivian LamDivision of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
Melissa MazorDivision of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Lia MetzgerNew York Medical College, Valhalla, New York, USA.
Carolyn J PresleyDivision of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.ORCID 0000-0002-2607-5639
Grant R WilliamsDivisions of Hematology/Oncology & Gerontology, Geriatrics, and Palliative Care, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kah Poh LohJames P. Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA.
Carling J UrsemDivision of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
Terence W FriedlanderDivision of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
Collin M BlakelyDivision of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
Matthew A GubensDivision of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
Gregory AllenDivision of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
Dianne ShumayDepartment of Psychiatry, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA.
Louise C WalterDivision of Geriatrics, University of California, San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
San Francisco VA Medical Center · USUniversity of California, San Francisco · USDuke University · USIcahn School of Medicine at Mount Sinai · USNew York Medical College · USSan Francisco General Hospital · USThe Ohio State University · USUniversity of Alabama at Birmingham · USUniversity of Rochester Medical Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANTP30CA196521 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ramon E Parsons · 2015 to 2026
$35.4M
VARC CoreP30AG044281 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alexander Keliimoeanu Smith · 2013 to 2026
$19.9M
Institutional Career Development Core SupplementKL2TR001870 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KANAYA, ALKA M., SARKAR, URMIMALA · 2016 to 2025
$19.7M
Training Program in Cancer Prevention and Control for Priority PopulationsT32CA225617 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Guy H Montgomery, JUAN P WISNIVESKY · 2018 to 2026
$2.6M
Advancing patient-centered decision making in older adults with lung cancer: Incorporating risk of functional decline into treatment discussionsK76AG064431 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WONG, MELISA L · 2019 to 2023
$1.3M
Mentoring Researchers in Prognosis Research in Alzheimer’s Disease and Related DementiasK24AG068312 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alexander Keliimoeanu Smith · 2020 to 2026
$1.2M
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M StudyK08CA234225 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WILLIAMS, GRANT R · 2018 to 2022
$1.0M
A Novel Mobile Health Exercise Intervention for Older Patients with Myeloid NeoplasmsK99CA237744 · NCI · UNIVERSITY OF ROCHESTER · PI LOH, KAH POH · 2019 to 2020
$385k
Expanding the Definition of Treatment Toxicity in Older Adults with Lung CancerR03AG056439 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WONG, MELISA L · 2017 to 2018
$238k
Resiliency Among Older Adults Receiving Lung Cancer Treatment (ROAR-LCT): A Pilot Intervention StudyR03AG064374 · NIA · OHIO STATE UNIVERSITY · PI PRESLEY, CAROLYN · 2019 to 2020
$232k
NCATS NIH HHS KL2 TR001870NCATS NIH HHS KL2TR001870NCI NIH HHS K08 CA234225NCI NIH HHS K08CA234225NCI NIH HHS K99 CA237744NCI NIH HHS K99CA237744NCI NIH HHS P30 CA016058NCI NIH HHS P30CA016058NCI NIH HHS P30 CA196521NCI NIH HHS P30CA196521NCI NIH HHS T32 CA225617NCI NIH HHS T32CA225617NIA NIH HHS K24 AG068312NIA NIH HHS K24AG068312NIA NIH HHS K76 AG064431NIA NIH HHS K76AG064431NIA NIH HHS P30 AG044281NIA NIH HHS P30AG044281NIA NIH HHS R03 AG056439NIA NIH HHS R03AG056439NIA NIH HHS R03 AG064374NIA NIH HHS R03AG064374
6 · The paper itself

Abstract

backgroundMaintenance of function during cancer treatment is important to older adults. Characteristics associated with pretreatment life-space mobility and changes during non-small cell lung cancer (NSCLC) treatment remain unknown.

methodsThis mixed methods cohort study recruited adults age ≥65 with advanced NSCLC starting palliative chemotherapy, immunotherapy, and/or targeted therapy from a Comprehensive Cancer Center, Veterans Affairs, and safety-net clinic. Patients completed geriatric assessments including Life-Space Assessment (LSA) pretreatment and at 1, 2, 4, and 6 months after treatment initiation. LSA scores range from 0 to 120 (greater mobility); LSA <60 is considered restricted. We used mixed-effects models to examine pretreatment LSA, change from 0 to 1 month, and change from 1 to 6 months. A subgroup participated in semistructured interviews pretreatment and at 2 and 6 months to understand the patient experience of life-space change. For each interview participant, we created joint displays of longitudinal LSA scores juxtaposed with illustrative quotes.

resultsAmong 93 patients, median age was 73 (range 65-94). Mean pretreatment LSA score was 67.1. On average, LSA declined 10.1 points from pretreatment to 1 month and remained stable at 6 months. Pretreatment LSA score was associated with several demographic, clinical, geriatric assessment, and symptom characteristics. LSA decline at 1 month was greater among patients with high anxiety (slope = -12.6 vs. -2.3, p = 0.048). Pretreatment body mass index <21 kg/m

conclusionOlder adults with NSCLC have low pretreatment life space with many developing restricted life space during treatment. Incorporating life-space assessments into clinical cancer care may help older adults concretely visualize how treatment might impact their daily function to allow for informed decision making and identify early changes in mobility to implement supportive interventions.

Indexed as

Activities of Daily LivingGeriatric AssessmentAgedAged, 80 and overCarcinoma, Non-Small-Cell LungFemaleHumansLung NeoplasmsMaleMobility LimitationProspective Studiescancer treatmentgeriatric oncologylife-space mobilitylung cancermixed methods

Identifiers

PMID34611887
PMCPMC8742783
OpenAlexW3202649090

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.